OMAR DAABIES: Open Payments
NPI 1578179479 · BRANDON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$37,210 in 252 payments from 23 companies in 2025. Trend: 2023 $1,606 · 2024 $4,978 · 2025 $37,210
Speaker / faculty: $21,838Food & beverage: $7,037Travel & lodging: $5,154Consulting: $3,000Education: $181
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 42 | $20,737 |
| Janssen Biotech, Inc. | 34 | $7,226 |
| Arcutis Biotherapeutics, Inc. | 21 | $4,977 |
| ABBVIE INC. | 31 | $697 |
| Regeneron Healthcare Solutions, Inc. | 22 | $664 |
| Botanix SB Inc | 12 | $452 |
| PFIZER INC. | 19 | $438 |
| UCB, Inc. | 9 | $376 |
| GENZYME CORPORATION | 9 | $308 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $231 |
Products named: NEMLUVIO, TREMFYA, Zoryve, DUPIXENT, SKYRIZI, SOFDRA, CIBINQO, Bimzelx.
Industry payments across FL — which companies pay providers there.
